Overview

Drug discovery aims to find and develop molecules that act on disease-relevant targets or biological processes, while balancing efficacy, safety, and the ability to make them. AI methods include graph and 3D models for predicting molecular properties, binding, and toxicity; generative models for proposing or editing molecules; and knowledge graphs and omics models for prioritizing targets and interpreting biological responses. Search and design methods increasingly combine these predictions with docking, synthesis constraints, experimental data, and tools coordinated by AI agents. A central challenge is that strong results on standard benchmarks may not transfer to unseen targets, chemistry, or assays, and computational scores still need reliable experimental validation.

Latest papers

CardsList

178 papers15 papers in the last four weeks, down 37% on the four weeks before. 0.1% of all new papers.

  1. Few-Shot Bioactivity Prediction with Meta-Learning under Assay Heterogeneity

    Oct 5, 2026Michal Kmicikiewicz, Tommy Rochussen, Vincent Fortuin +1Meta-LearningFew-Shot Learning

  2. PharmAgent: Constraint-Aware Search with Frozen Language Models for Molecular Optimization

    Oct 4, 2026Nihui Shao, Guanxing Chen, Jilong Shi +6Molecular OptimizationLarge Language Model-Guided Optimization

  3. Toward a Locally Deployable Agentic Co-Scientist: Small-Model Planning for Early-Stage Drug Discovery

    Oct 3, 2026Tian Liang, Jiayu Chang, Alejandro F. Frangi +2LLM Tool UseLLM Agent Planning

  4. Multimodal reasoning for broadly neutralizing antibody discovery from label-free human B cell repertoires across virus families

    Oct 2, 2026Hantao Lou, Jianqing Zheng, Can Yue +21Drug DiscoveryAI Agents for Scientific Discovery

  5. R-GroundBench: A Diagnostic Benchmark for R-Group Groundingin Markush Molecular Editing

    Sep 30, 2026Xin Wang, Zichuan Ying, Xinna Lin +8Vision-Language GroundingDrug Discovery

  6. TopU-LBVS: A Realistic Multi Target Benchmark for Ligand Based Virtual Screening

    Sep 24, 2026Surbhi Kumar, Yuhe Zhou, Varun Shiralkar +2Benchmark DesignVirtual Screening

  7. Adapting Boltz-2 with limited experimental activity data improves early enrichment in virtual screening

    Sep 21, 2026Kairi Furui, Masahito OhueProtein-Ligand Binding Affinity PredictionVirtual Screening

  8. CurvFlow-DTA: dual-graph discrete Ricci curvature flow for drug--target affinity prediction

    Sep 19, 2026Jicheng Ma, Yunyan Yang, Juan Zhao +1Protein-Ligand Binding Affinity PredictionDrug Discovery

  9. MIRCID: Inferred Hub-miRNAs Drive Cross-Task Improvements in Drug Mechanistic Modeling

    Sep 18, 2026Xin Cao, Yigang Chen, Jiatong Xu +11Drug Discovery

  10. Evidence-Grounded Agentic Formulation Development in an Autonomous Laboratory

    Sep 16, 2026Michael M. Craig, Riley J. Hickman, Yingshan Ma +3Autonomous ExperimentationAutonomous Research Agents

  11. A Systematic Evaluation of Molecule Generation Models for De Novo Drug Design: From Benchmarks to Practical Insights

    Sep 9, 2026Xinrui Xu, Xueer Wang, Dan Luo +2Structure-Based Drug DesignMolecular Generation

  12. Training Large Language Models for Small-Molecule Design with Synthetic Task Scaling

    Sep 4, 2026Frank Hu, Shriram Chennakesavalu, Zichen Wang +5Molecule DesignLLM Training

  13. ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

    Sep 2, 2026Quan Hao, Mengyue Fan, Zifan Dong +8Drug DiscoveryAI-Assisted Scientific Research

  14. Predicting Dose-Response Success from Primary Screening Data

    Aug 27, 2026Sean LimDose-Response EstimationDrug Discovery

  15. VINCENT: Validated Interaction Network for Cross-drug Explanation of Therapeutics

    Aug 26, 2026Fan-Sheng Chuang, Xuchen Li, Yujing Bian +1Drug DiscoveryDrug-Drug Interaction Prediction

  16. Mol-JEPA: A multimodal Joint Embedding Predictive Architecture for Molecules

    Aug 23, 2026Florian Rottach, Sebastian Schieferdecker, William Rudman +2Joint-Embedding Predictive ArchitectureMultimodal Pretraining

  17. Designing a Robust LLM-Based Evaluation System for Agentic AI in Drug Discovery Through Human Alignment

    Aug 21, 2026Emma Granqvist, Rocío Mercado, Samuel GenhedenAI Agents for Scientific DiscoveryLLM-as-a-Judge

  18. PETA:Parameter-Efficient Test-Time Adaptation for Virtual Screening

    Aug 20, 2026Jia-Qi Lin, Yinghua Yao, Chang-Dong Wang +2Virtual ScreeningTest-Time Adaptation

  19. PGFS++: Molecular Property Improvement under Synthesis and Diversity Constraints

    Aug 19, 2026Boqiao Zhang, Godbless James, Sai Krishna Gottipati +1Molecular OptimizationMolecule Design

  20. Rigorous Evaluation of Large Language Models for Malaria Drug Discovery: Trade-offs in Performance, Scale, and Resource Utility

    Aug 18, 2026Marvellous O. Ajala, Zainab Ashimiyu-Abdusalam, Comfort AdesinaDrug DiscoveryLLM Evaluation

  21. Recent Advances in Deep Learning-Based Drug-Target Binding Affinity Prediction

    Aug 13, 2026Jafin Khan, Md Hossain ShuvoProtein-Ligand Binding Affinity PredictionDrug Discovery

  22. ScreenShot: A Foundation Model for Few-Shot Combination Drug Screening

    Aug 12, 2026Antoine de Mathelin, Christopher Tosh, Wesley TanseyFew-Shot LearningDrug Discovery

  23. Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling

    Aug 11, 2026Vincent Lavelle, Yitan Zhu, Kaitlyn Marlor +2Benchmark DesignOOD Generalization

  24. Genotypic Triggers: Exposing Pharmacogenomic Blind Spots via Host-Specific Backdoors in Generative Antimicrobial Peptide Models

    Aug 7, 2026Doniyorkhon Obidov, Xiaolong Guo, Yonghui Li +1Backdoor AttacksMolecular Generation

  25. MolBioKG: Grounding Out-of-Graph Molecules in Biomedical Knowledge Graphs via Multi-Resolution Structural Anchoring

    Aug 7, 2026Yiming Zhang, Hikaru Shindo, Shuan Chen +5Knowledge GraphsDrug Discovery

  26. Hit Selection Using SSMD-Based Machine Learning Performance Metrics in High-Throughput Screening Assays

    Aug 6, 2026Xiaohua Douglas ZhangDrug Discovery

  27. EpiBench: Can LLMs Understand Epitopes for Antibody Drug Discovery?

    Aug 6, 2026Zirui Wang, Jiaqi Wang, Qinghan Wang +4LLM EvaluationDrug Discovery

  28. Learning Molecular Representations from Cellular Phenotypes with Structure Preservation

    Aug 3, 2026Xuan Lin, Jingyu Sheng, Tengfei Ma +2Disentangled Representation LearningCross-Modal Representation Learning